Search
for

    Sort by

    Research 5

    1. Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome F&S Reports · 2023 · 2 citations
    2. Industry update: the latest developments in the field of therapeutic delivery, July 2018 Therapeutic Delivery · 2018 · 1 citations
    3. Skin manifestations of hyperandrogenism: an update HORMONES · 2026
    4. Real-world pharmacovigilance insights into drug-induced risk of alopecia Frontiers in Pharmacology · 2025
    5. 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011) Annals of Oncology · 2022 · 2 citations